Replast CBF Komp. B

Würth Norge AS

Revision date : 2021-11-29

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07 GHS08
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

101-68-8

Name of the chemical

4,4’-Methylenediphenyl diisocyanate

Concentration

N/A

EC/CAS

202-966-0

Name of the chemical

4,4'-Methylendiphenyldiisocyanat 2,2'-Methylendiphenyldiisocyanat 2,4'-Methylendiphenyldiisocyanat Methylendiphenyldiisocyanat (790/2009)

Concentration

N/A

General Information

Revision date

2021-11-29

Product name

Replast CBF Komp. B

1.2.1 Relevant identified uses

Foams, Sealant

Icons in SDS

Company Information

company name

Würth Norge AS

e-mail address of the competent person responsible for the Safety Data Sheet

prodsafe@wuerth.com

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H315, H317, H319, H332, H334, H335, H351, H373

Hazard statements

Code

Statements

H315

Causes skin irritation

Section 2

CLP CLASSIFICATION

Acute toxicity, Category 4 H332: Harmful if inhaled. Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Respiratory sensitisation, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Specific target organ toxicity - single ex- H335: May cause respiratory irritation. posure, Category 3 Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure.

2.2 Label elements

REGULATION (EC) No 1272/2008)

Signal word

Danger

Hazard statements

H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H332 Harmful if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure.

Prevention

P201 Obtain special instructions before use. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.

Response

P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention.

Hazardous Ingredients

4,4'-Methylenediphenyl diisocyanate, oligomers Methylenediphenyl diisocyanate, oligomeric reaction products with butanediol, tripropylene glycol and propanediol 4,4'-Diphenylmethane diisocyanate

Additional information

As from 24 August 2023 adequate training is required before industrial or pro- fessional use."

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Excessive exposure may aggravate preexisting asthma and other respiratory disorders (e.g. em- physema, bronchitis, reactive airways dysfunction syndrome).

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.